In vitro activity of meropenem against ciprofloxacin-resistant Enterobacteriaceae and Pseudomonas aeruginosa

Journal of Chemotherapy

Volumn 8, Issue 5, 1996, Pages 358-364

  Garcia Rodriguez, J A ^a,b   Blazquez, A M ^a   Fresnadillo, M J ^a   Garcia Sanchez, E ^a   Garcia Sanchez, J E ^a   Trujillano Martin, I ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Enterobacteriaceae; Meropenem; P. aeruginosa; Susceptibility of quinolone resistant bacteria

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TAZOBACTAM; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTER; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 0029854421     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.5.358     Document Type: Article

References (9)

1. Hooper DC, Wolfson JS. Mechanisms of bacterial resistance to quinolones. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Agents. Washington, DC: American Society for Microbiology, 1993: 97-118.
2. Poole K. Bacterial multidrug resistance - emphasis on efflux mechanisms and Pseudomonas aeruginosa. J Antimicrob Chemother 1994; 34: 453-6.
3. Wiedemann B, Heisig P. Quinolone resistance in Gram-negative bacteria. Infect Dis Clin Pract 1994; 3 (Suppl. 3): S115-S24.
4. aI, García Sánchez E, García Sánchez JE, Trujillano I, the Spanish Study Group on Quinolone Resistance. Multicenter Spanish study of ciprofloxacin susceptibility in Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1995; 14: 456-9.
5. Working Party of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 (Suppl. D): 1-9.
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing, M100-S6. NCCLS, Villanova, Pa.1995.
7. Livingstone D, Gill MJ, Wise R. Mechanisms of resistance to the carbapenems. J Antimicrob Chemother 1995; 35: 1-5.
8. Yourassowsky E, Van der Linden MP, Crokaert F. Antibacterial effect of meropenem and imipenem on Proteus mirabilis. J Antimicrob Chemother 1990; 26: 185-92.
9. Alarcón T, Pita J López-Brea M, Piddock LJV. High-level quinolone resistance among clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain. J Antimicrob Chemother 1993; 32: 605-9.